Catalyst
Slingshot members are tracking this event:
Novo Nordisk (NVO) receives US FDA approval for Xultophy 100/3.6
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| NVO | Community voting in process | |||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Nov 21, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Xultophy, Fda Approval, Type 2 Diabetes Mellitus
